We are live on ! Find out more
RLYB icon

Rallybio

32 hedge funds and large institutions have $63.3M invested in Rallybio in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

7.56% less ownership

Funds ownership: 76.85% → 69.29% (-7.6%)

14% less funds holding

Funds holding: 37 → 32 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

82% less capital inflows, than outflows

Capital inflows: $1.33M | Capital outflows: $7.51M

Holders
32
Holders Change
-5
Holders Change %
-13.51%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
9
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

RLYB Hedge Fund Activity: Q3 2026 in Review

32 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q3 2026, worth a combined $63.3M — down 2.7% from $65M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of RLYB and 3 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 9 added.

The largest buyer was Two Sigma Investments, adding an estimated $439K. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $3.01M sold.

  • 32 institutional investors held Rallybio (RLYB) as of Q3 2026, down from 37 in Q2 2026.
  • Funds reported $63.3M of Rallybio stock for Q3 2026, down 2.7% quarter-over-quarter.
  • 3 funds opened new Rallybio positions in Q3 2026 and 8 closed out, a net change of -5 holders.
  • The largest Rallybio buyer in Q3 2026 was Two Sigma Investments, an estimated $439K added.
  • The largest Rallybio seller in Q3 2026 was Nantahala Capital Management, an estimated $3.01M sold.

Based on aggregated 13F filings for Q3 2026.